UpStart Ventures

About The Fund

UpStart Ventures is a venture capital firm that focuses on funding breakthrough life science startups, offering compelling investment potential. Since their establishment in 2009, they primarily invest in seed and early-stage healthcare companies that are harnessing breakthrough technologies from major research universities. UpStart Ventures has a keen interest in the Biotech, Medical Devices, Life Science, and Women-Focused industries. They take a hands-on approach to investment, believing that they can generate significantly more value through the formation and initial management of cutting-edge life science companies, rather than through traditional venture capital investments in pre-existing companies at early or later stages. UpStart Ventures specializes in Equity investments, with specific expertise in areas such as Expansion, MBO/LBO, as well as Seed stages. They maintain a strong focus on medical devices, drug delivery systems, diagnostics, and longer-term investments in biopharma products and platforms, centering their efforts around Utah and neighboring states. UpStart Ventures is equally committed to locating the right science and technology, partnering with leading academics, incubating companies while maintaining cash efficiency, sourcing non-dilutive capital, and providing expertise in technology company growth and exit strategies. With assets under management around $20,000,000, UpStart Ventures aims to create significant value from the outset of their investments, which is evidenced by their portfolio success stories such as XableCath which received multiple FDA clearances for its medical devices and Q Therapeutics' joint venture and research collaboration. Their headquarters address is 444 Madison Avenue, 25th Floor, New York, New York, 10022, United States, signalling their presence in a key hub for finance and innovation.